FDA advisers vote against Avastin for breast cancer treatment
Wednesday, June 29, 2011 - 18:11
in Health & Medicine
Though the FDA will make the final decision, it rarely ignores recommendations of its advisers.
Though the FDA will make the final decision, it rarely ignores recommendations of its advisers.